Global PDX Models Market– Industry Trends and Forecast to 2025

  • Healthcare IT
  • Published Report
  • Jul 2018
  • Global
  • 200 Pages
  • No of Tables: 55
  • No of Figures: 147

Global PDX Models Market, By Type (Mice Models, Rat Models), Tumor Type (Respiratory Tumor Models, Urological Tumor Models, Gastrointestinal Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Others), Application (Preclinical Drug Development & Oncology Research, Biomarker Analysis), End User (Contract Research Organization, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)- Industry Trends and Forecast to 2025

Global PDX Models Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Global PDX models marketProminent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization. However, due to high cost of PDX models and strict regulations with respect to the utilization of animal models in cancer research are hindering the market growth.

Market Segmentation: Global PDX Models Market

  • The global PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.
  • The global PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
  • The global PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
  • The global PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
  • Based on geography, the market is segmented into 5 geographical regions

    •  North America
    • Europe
    • Asia-Pacific
    • South America and
    • Middle East & Africa

Key Drivers: Global PDX Models Market

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

Key Points: Global PDX Models Market

Charles River is going to dominate the PDX models market following with Crown Bioscience Inc., Champion Oncology, Inc., The Jackson Laboratory, Oncodesign, Wuxi Apptec, Horizon Discovery Group plc, Pharma test Services Ltd, Aragen Bioscience (Subsidiary of GVK Biosciences Private Limited), MI Bioresearch Inc., EUROPDX, Creative Animodel, Urolead, Xentech, Hera BioLabs and EPO BERLIN-BUCH GMBH among others.

  • The mice models segment is dominating the global PDX models market.
  • Respiratory tumor models segment is expected to grow with the highest CAGR of 15.3% in the forecast period 2018 to 2025.

SKU-
CHOOSE LICENCE TYPE
  • 5400.00
  • 4200.00
BUY NOW ADD TO CART